The efficacy and predictive value of 99mTc-rituximab for sentinel lymph node biopsy in acral melanoma patients

Abstract Background We sought to evaluate the efficacy and predictive value of 99mTc-rituximab as a tracer for sentinel lymph node biopsy (SLNB) in acral melanoma (AM) patients. Methods We retrospectively analyzed data from 663 melanoma patients who underwent SLNB in our center between February 2009...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ruifeng Xue, Zhiyan Liu, Zhichao Tan, Yujun Cui, Chujie Bai, Shu Li, Tian Gao, Lu Zhang, Xinyu Wang, Zhengfu Fan, Jiayong Liu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2026-05-01
Colección:	World Journal of Surgical Oncology
Materias:	Acral melanoma 99mTc-rituximab Sentinel lymph node biopsy False negative
Acceso en línea:	https://doi.org/10.1186/s12957-026-04394-4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!